Accelerate Diagnostics, Inc.
AXDXNASDAQHealthcare
$0.03
+$0.00(+0.00%)
Market Cap$859918
P/E Ratio—
52W High$2.09
52W Low$0.01
Accelerate Diagnostics, Inc. (AXDX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AXDX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $11.70M | $12.06M | $12.75M | $11.78M | $11.16M |
| Cost of Revenue | $8.99M | $9.51M | $9.45M | $12.16M | $6.71M |
| Gross Profit | $2.70M | $2.55M | $3.30M | ($0.38M) | $4.46M |
| Gross Margin %(computed) | 23.12% | 21.15% | 25.90% | -3.23% | 39.94% |
| Operating Expenses | |||||
| R&D Expenses | $16.69M | $25.35M | $26.91M | $21.94M | $21.25M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $38.01M | $56.58M | $66.11M | $71.18M | $68.16M |
| Operating Income | ($35.31M) | ($54.03M) | ($62.80M) | ($71.56M) | ($63.70M) |
| Operating Margin %(computed) | -301.85% | -448.03% | -492.51% | -607.37% | -570.53% |
| Interest Income | $0.70M | $1.12M | $0.55M | $0.09M | $0.85M |
| Interest Expense | $13.12M | $7.74M | $3.77M | $15.54M | $15.55M |
| Income Before Tax | ($50.11M) | ($60.77M) | ($62.57M) | ($77.66M) | ($78.20M) |
| Income Tax Expense | ($0.07M) | $0.85M | ($0.08M) | $0.04M | $0.01M |
| Net Income | ($50.05M) | ($61.62M) | ($62.49M) | ($77.70M) | ($78.21M) |
| Net Margin %(computed) | -427.81% | -510.97% | -490.06% | -659.50% | -700.47% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.15 | $-4.94 | $-7.61 | $-12.59 | $-13.96 |
| Wtd Avg Shares | 23.30M | 12.48M | 8.22M | 6.17M | 5.60M |
| EBITDA | ($33.57M) | ($49.77M) | ($55.80M) | ($59.59M) | ($59.66M) |
| EBITDA Margin %(computed) | -287.00% | -412.73% | -437.57% | -505.81% | -534.31% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Accelerate Diagnostics, Inc. data
About Accelerate Diagnostics, Inc. (AXDX) Income Statement
Accelerate Diagnostics, Inc. (AXDX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, AXDX reported revenue of $0.01B, gross profit of $0.00B (gross margin 23.12%), and net income of ($0.05B) — a net profit margin of -427.81%.
Frequently asked questions
AXDX · 4 questionsAccelerate Diagnostics, Inc. (AXDX) reported revenue of $0.01B for 2024, down 3.0% year-over-year.
AXDX revenueAXDX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09